Causal association of long COVID with brain structure changes: Findings from a 2-sample Mendelian randomization study

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work has been supported by NIH National Institute of Aging, USA R01 AG057557, R01 AG061388, R56 AG062272, National Institute on Alcohol Abuse and Alcoholism, USA (grant no. R01AA029831). This work was also partially supported by grant HG011052 and HG011052-03S1 from the National Human Genome Research Institute (NHGRI), USA.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The source data were openly available before the initiation of the study. In this study, we used GWAS summary statistics of long COVID (Lammi et al., 2023) (N =3,018 for cases and 994,582 for controls, available from https://www.medrxiv.org/node/671137.external-links.html) and GWAS summary statistics of brain structure (global and regional cortices (Grasby et al., 2020), N = 33,709, available from http://enigma.ini.usc.edu/research/download-enigma-gwas-results; combined hemispheric subcortical regions (Satizabal et al., 2019), N = 38,851, available from http://enigma.ini.usc.edu/research/download-enigma-gwas-results; and left/right subcortices (Zhao et al., 2019), N = 19,629, available from https://github.com/BIG-S2/GWAS).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes